Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097227
Status:
COMPLETED
Last Update Posted:
2010-04-09
First Post:
2004-11-18
Brief Title:
Trial of CarboplatinPaclitaxelCetuximab in Stage IIIBIV Non-Small Cell Lung Cancer NSCLC
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company